注射用益气复脉(冻干)在高龄患者应用中的安全性

Safety of Yiqi Fumai Lyophilized Injection in elderly patients

目的探讨注射用益气复脉(冻干)在高龄患者应用中的安全性。方法回顾性分析天津医科大学总医院2017年7月—2017年12月,106例80岁及80岁以上应用注射用益气复脉(冻干)治疗的高龄患者的临床资料。结果 106例高龄患者应用注射用益气复脉(冻干)治疗,治疗前、后药物对患者肝肾功能均无不良影响,且其余不良反应轻微。结论高龄患者应用注射用益气复脉(冻干)具有很好的安全性,且患者耐受性良好。

Objective To detective the safety of Yiqifumai Lyophilized Injection（YQFM） in the elderly patients. Methods A retrospective analysis was made on the clinical data of 106 elderly patients who were equal to or greater than 80 years old treated by YQFM in our department from July 2017 to December 2017. Results 106 elderly patients was treated by YQFM. Before and after treatment, YQFM had no adverse effects on liver and kidney function, and the other adverse reactions were slight. Conclusions YQFM used in the elderly patients had good safety and tolerance was well.